<?xml version="1.0" encoding="UTF-8"?>
<p>Angiotensin II activates NF-κB in monocytes with proinflammatory effects, and RAS inhibitors also decrease NF-κB activation and neutrophil chemotaxis (
 <xref rid="b115-ijmm-46-02-0489" ref-type="bibr">115</xref>). Moreover, angiotensin converting enzyme (ACE) affects pulmonary vascular tone and permeability, epithelial cell apoptosis, and lung fibrosis via fibroblast activation so that RAS inhibitors may be beneficial in ARDS.
</p>
